<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H8516378E9BF043049BA665CED064D849" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8988 IH: Electronic Prescribing for Controlled Substances Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-09-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8988</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220926">September 26, 2022</action-date><action-desc><sponsor name-id="O000171">Mr. O'Halleran</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committees on <committee-name committee-id="HED00">Education and Labor</committee-name>, and <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage.</official-title></form><legis-body id="H28A110CEB0A448458546B5E279857AA7" style="OLC"><section id="HA0BAE83E22884684A4501DE8A596DD93" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Electronic Prescribing for Controlled Substances Act</short-title></quote> or the <quote><short-title>EPCS 2.0 Act</short-title></quote>. </text></section><section id="H115A8AE1156B48288AF92B2BD7F134BA"><enum>2.</enum><header>Requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage</header><subsection id="HA9C23DE8311E476EAAA99EAB1018861C"><enum>(a)</enum><header>Public Health Service Act amendment</header><text>Section 2799A–7 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-117">42 U.S.C. 300gg–117</external-xref>) is amended by adding at the end the following new subsection: </text><quoted-block id="HBEC84446994C45A0BE57498AD61F9259" style="OLC"><subsection id="HA485C7D4E61641749ACCCCCB5603A799"><enum>(d)</enum><header>Requirements for electronic-Prescribing for controlled substances</header><paragraph id="HAE3B632CBE7A4E79A046A6AE38896218"><enum>(1)</enum><header>In general</header><text>Except as provided pursuant to paragraph (2), for plan years beginning on or after January 1, 2024, a group health plan and a health insurance issuer offering group or individual health insurance coverage shall, with respect to health care practitioners that have a contractual relationship with such plan or issuer for furnishing items or services to participants and beneficiaries under such plan or coverage, have in place policies, subject to paragraph (4), that require any prescription for a schedule II, III, IV, or V controlled substance (as defined by section 202 of the Controlled Substances Act) covered under the plan or coverage that is transmitted by such a health care practitioner for such a participant or beneficiary be electronically transmitted in accordance with such standards, consistent with standards established under paragraph (3) of section 1860D–4(e) of the Social Security Act, under an electronic prescription drug program that meets requirements that are substantially similar (as jointly determined by the Secretary, Secretary of the Treasury, and Secretary of Labor) to the requirements of paragraph (2) of such section 1860D–4(e).</text></paragraph><paragraph id="H7847D2F997C84798BA044C569E977DEC"><enum>(2)</enum><header>Exception for certain circumstances</header><text>The Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly, through rulemaking, specify circumstances and processes by which the requirement under paragraph (1) may be waived, with respect to a schedule II, III, IV, or V controlled substance that is a prescription drug covered by a group health or group or individual health insurance coverage offered by a health insurance issuer, including in the case of—</text><subparagraph id="H512493E1D6EE4AD68AEE0F69AC2AD906"><enum>(A)</enum><text>a prescription described in any of clauses (i) through (vi) of section 1860D–4(e)(7)(B) of the Social Security Act; </text></subparagraph><subparagraph id="H4FAA233AC8CC4484A8511803EBEA1012"><enum>(B)</enum><text>a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure, as specified jointly by the Secretary, Secretary of the Treasury, and Secretary of Labor through rulemaking; and</text></subparagraph><subparagraph id="H6E5823FD775C416E889CAE797C7A8E3A"><enum>(C)</enum><text>a prescription issued by a practitioner allowing for the dispensing of a non-patient specific prescription pursuant to a standing order, approved protocol for drug therapy, collaborative drug management, or comprehensive medication management, in response to a public health emergency or other circumstances under which the practitioner may issue a non-patient specific prescription.</text></subparagraph></paragraph><paragraph id="H943761C75E5A4982BD5333C7BBEF83C3"><enum>(3)</enum><header>Rules of Construction</header><subparagraph id="H9A7C0EA88573461DB57B972AAD14A2C8"><enum>(A)</enum><header>Verification</header><text>Nothing in this subsection shall be construed as requiring a dispenser to verify that a health care practitioner, with respect to a prescription for a schedule II, III, IV, or V controlled substance that is a prescription drug covered under a group health plan or group or individual health insurance coverage offered by a health insurance issuer, has a waiver (or is otherwise exempt) under paragraph (2) from the requirement under paragraph (1).</text></subparagraph><subparagraph id="HE022C214B0834331B54E53B3BFF2CD53"><enum>(B)</enum><header>Authority to dispense</header><text>Nothing in this subsection shall be construed as affecting the ability of a group health plan or group or individual health insurance coverage offered by a health insurance issuer to cover, or the ability of a pharmacist to continue to dispense, a prescription drug if the prescription for such drug is an otherwise valid written, oral, or fax prescription that is consistence with applicable laws and regulations.</text></subparagraph><subparagraph id="H0CE2E659596A4D279D99A7A9B798771E"><enum>(C)</enum><header>Patient choice</header><text display-inline="yes-display-inline">Nothing in this subsection shall be construed as affecting the ability of an individual who is a participant or beneficiary of a group health plan or group or individual health insurance coverage offered by a health insurance issuer and who is being prescribed a schedule II, III, IV, or V controlled substance that is a prescription drug covered under the plan or coverage to designate a particular pharmacy to dispense such controlled substance to the extent consistent with the requirements under this subsection.</text></subparagraph></paragraph><paragraph id="H9AA3492EAC454382A44CF37FD6B4ACB6"><enum>(4)</enum><header>Prohibitions</header><text>The policies established pursuant to paragraph (1) by a group health plan or health insurance issuer offering group or individual health insurance coverage may not—</text><subparagraph id="H6DC6D1BA40FF44ADA2C7000AD08486AE"><enum>(A)</enum><text display-inline="yes-display-inline">require dispensers of a schedule II, III, IV, or V controlled substance to confirm that the prescription for the controlled substance was electronically issued by a health care practitioner in accordance with such policies, as described in paragraph (1); </text></subparagraph><subparagraph id="H89BD17CFF56C42CBA693879E25C20FD7"><enum>(B)</enum><text>require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a practitioner’s compliance with such policies; or</text></subparagraph><subparagraph id="H0AB2CE5E8C054540AE3E329974B05009"><enum>(C)</enum><text>reject, deny, or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued.</text></subparagraph></paragraph><paragraph id="HF869A3837E47499E9B0EE67F2BD43BDA"><enum>(5)</enum><header>Consultation requirement for rulemaking</header><text>In promulgating regulations to carry out this subsection, the Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly consult with dispensers of controlled substances, State insurance regulators, and health care practitioners.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H746D3FA9615D417CA1C5EF331BD60ABE"><enum>(b)</enum><header>Employee Retirement Income Security Act of 1974 amendment</header><text display-inline="yes-display-inline">Section 722 of the Employee Retirement Income Security Act of 1974 (<external-xref legal-doc="usc" parsable-cite="usc/29/1185k">29 U.S.C. 1185k</external-xref>) is amended by adding at the end the following new subsection:</text><quoted-block style="OLC" id="HE954117B9AFA433F8E3DDD91A6CBEB02" display-inline="no-display-inline"><subsection id="HFCF37CAB85424A4F88CE05711C92F9F0"><enum>(d)</enum><header>Requirements for electronic-Prescribing for controlled substances</header><paragraph id="H02D8352AF7DF4DA1AF46025F0BE13164"><enum>(1)</enum><header>In general</header><text>Except as provided pursuant to paragraph (2), for plan years beginning on or after January 1, 2024, a group health plan and a health insurance issuer offering group health insurance coverage shall, with respect to health care practitioners that have a contractual relationship with such plan or issuer for furnishing items or services to participants and beneficiaries under such plan or coverage, have in place policies, subject to paragraph (4), that require any prescription for a schedule II, III, IV, or V controlled substance (as defined by section 202 of the Controlled Substances Act) covered under the plan or coverage that is transmitted by such a health care practitioner for such a participant or beneficiary be electronically transmitted in accordance with such standards, consistent with standards established under paragraph (3) of section 1860D–4(e) of the Social Security Act, under an electronic prescription drug program that meets requirements that are substantially similar (as jointly determined by the Secretary, Secretary of the Treasury, and Secretary of Labor) to the requirements of paragraph (2) of such section 1860D–4(e).</text></paragraph><paragraph id="H278498148D584AFCA267930F8D760264"><enum>(2)</enum><header>Exception for certain circumstances</header><text>The Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly, through rulemaking, specify circumstances and processes by which the requirement under paragraph (1) may be waived, with respect to a schedule II, III, IV, or V controlled substance that is a prescription drug covered by a group health or group health insurance coverage offered by a health insurance issuer, including in the case of—</text><subparagraph id="H70FE86120D6140259EB22C95EB53FF6E"><enum>(A)</enum><text>a prescription described in any of clauses (i) through (vi) of section 1860D–4(e)(7)(B) of the Social Security Act; </text></subparagraph><subparagraph id="H285B91E88C1E4D549041DA27EDE413B5"><enum>(B)</enum><text>a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure, as specified jointly by the Secretary, Secretary of the Treasury, and Secretary of Labor through rulemaking; and</text></subparagraph><subparagraph id="H48605FCDA49B44CFBA30BB003B74D00B"><enum>(C)</enum><text>a prescription issued by a practitioner allowing for the dispensing of a non-patient specific prescription pursuant to a standing order, approved protocol for drug therapy, collaborative drug management, or comprehensive medication management, in response to a public health emergency or other circumstances under which the practitioner may issue a non-patient specific prescription.</text></subparagraph></paragraph><paragraph id="H3C897D084E7B44E3807CCEF6F6F33919"><enum>(3)</enum><header>Rules of Construction</header><subparagraph id="H6C2F15AB13D349F1962D4CB675471E8F"><enum>(A)</enum><header>Verification</header><text>Nothing in this subsection shall be construed as requiring a dispenser to verify that a health care practitioner, with respect to a prescription for a schedule II, III, IV, or V controlled substance that is a prescription drug covered under a group health plan or group or individual health insurance coverage offered by a health insurance issuer, has a waiver (or is otherwise exempt) under paragraph (2) from the requirement under paragraph (1).</text></subparagraph><subparagraph id="H868E09E417624015A6A4304BF7E8574A"><enum>(B)</enum><header>Authority to dispense</header><text>Nothing in this subsection shall be construed as affecting the ability of a group health plan or group health insurance coverage offered by a health insurance issuer to cover, or the ability of a pharmacist to continue to dispense, a prescription drug if the prescription for such drug is an otherwise valid written, oral, or fax prescription that is consistence with applicable laws and regulations.</text></subparagraph><subparagraph id="H66FC930D710E4BD1B5280ADD54333BAA"><enum>(C)</enum><header>Patient choice</header><text display-inline="yes-display-inline">Nothing in this subsection shall be construed as affecting the ability of an individual who is a participant or beneficiary of a group health plan or group or individual health insurance coverage offered by a health insurance issuer and who is being prescribed a schedule II, III, IV, or V controlled substance that is a prescription drug covered under the plan or coverage to designate a particular pharmacy to dispense such controlled substance to the extent consistent with the requirements under this subsection.</text></subparagraph></paragraph><paragraph id="HD31CC876F5B347B280A612ADEC93C631"><enum>(4)</enum><header>Prohibitions</header><text>The policies established pursuant to paragraph (1) by a group health plan or health insurance issuer offering group health insurance coverage may not—</text><subparagraph id="HBF30D1CB71374AFCB77257F4976429DE"><enum>(A)</enum><text display-inline="yes-display-inline">require dispensers of a schedule II, III, IV, or V controlled substance to confirm that the prescription for the controlled substance was electronically issued by a health care practitioner in accordance with such policies, as described in paragraph (1); </text></subparagraph><subparagraph id="H1D46648AA03E432E9B14095BC5825E89"><enum>(B)</enum><text>require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a practitioner’s compliance with such policies; or</text></subparagraph><subparagraph id="H4E0F79AB4B334C5BAEF3D238E9CD3CDF"><enum>(C)</enum><text>reject, deny, or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued.</text></subparagraph></paragraph><paragraph id="HF993E446BB7C4573B5E85DCA9C66E984"><enum>(5)</enum><header>Consultation requirement for rulemaking</header><text>In promulgating regulations to carry out this subsection, the Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly consult with dispensers of controlled substances, State insurance regulators, and health care practitioners.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H6171E62CBF444367914AA25CCE93CF67"><enum>(c)</enum><header>Internal Revenue Code of 1986 amendment</header><text><external-xref legal-doc="usc" parsable-cite="usc/26/9822">Section 9822</external-xref> of the Internal Revenue Code of 1986 is amended by adding at the end the following new subsection:</text><quoted-block style="OLC" id="HDB1779F4B007454CB429E2C9A239C289" display-inline="no-display-inline"><subsection id="H47447FCC84F7432E8372BC356584B93F"><enum>(d)</enum><header>Requirements for electronic-Prescribing for controlled substances</header><paragraph id="HDF6DC112F729472BA91B8C0A6352B91E"><enum>(1)</enum><header>In general</header><text>Except as provided pursuant to paragraph (2), for plan years beginning on or after January 1, 2024, a group health plan shall, with respect to health care practitioners that have a contractual relationship with such plan for furnishing items or services to participants and beneficiaries under such plan, have in place policies, subject to paragraph (4), that require any prescription for a schedule II, III, IV, or V controlled substance (as defined by section 202 of the Controlled Substances Act) covered under the plan that is transmitted by such a health care practitioner for such a participant or beneficiary be electronically transmitted in accordance with such standards, consistent with standards established under paragraph (3) of section 1860D–4(e) of the Social Security Act, under an electronic prescription drug program that meets requirements that are substantially similar (as jointly determined by the Secretary, Secretary of the Treasury, and Secretary of Labor) to the requirements of paragraph (2) of such section 1860D–4(e).</text></paragraph><paragraph id="HF9052B88915449A68210060E41A95B85"><enum>(2)</enum><header>Exception for certain circumstances</header><text>The Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly, through rulemaking, specify circumstances and processes by which the requirement under paragraph (1) may be waived, with respect to a schedule II, III, IV, or V controlled substance that is a prescription drug covered by a group health, including in the case of—</text><subparagraph id="H63C8A626FE834610923CC0567B4CE832"><enum>(A)</enum><text>a prescription described in any of clauses (i) through (vi) of section 1860D–4(e)(7)(B) of the Social Security Act; </text></subparagraph><subparagraph id="H5EB28E20A3E5414B8B350C9962A41A5C"><enum>(B)</enum><text>a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure, as specified jointly by the Secretary, Secretary of the Treasury, and Secretary of Labor through rulemaking; and</text></subparagraph><subparagraph id="H3470252D53F540EFA24EBFCEBCAAF4E8"><enum>(C)</enum><text>a prescription issued by a practitioner allowing for the dispensing of a non-patient specific prescription pursuant to a standing order, approved protocol for drug therapy, collaborative drug management, or comprehensive medication management, in response to a public health emergency or other circumstances under which the practitioner may issue a non-patient specific prescription.</text></subparagraph></paragraph><paragraph id="H943FB46F67D94406A51C0DC8D1FF32B4"><enum>(3)</enum><header>Rules of Construction</header><subparagraph id="H146999B156F54F0F9CAD772EA4ADC3F0"><enum>(A)</enum><header>Verification</header><text>Nothing in this subsection shall be construed as requiring a dispenser to verify that a health care practitioner, with respect to a prescription for a schedule II, III, IV, or V controlled substance that is a prescription drug covered under a group health plan, has a waiver (or is otherwise exempt) under paragraph (2) from the requirement under paragraph (1).</text></subparagraph><subparagraph id="H81AFD664DC474646B429BFFD5BB5D5F7"><enum>(B)</enum><header>Authority to dispense</header><text>Nothing in this subsection shall be construed as affecting the ability of a group health plan to cover, or the ability of a pharmacist to continue to dispense, a prescription drug if the prescription for such drug is an otherwise valid written, oral, or fax prescription that is consistence with applicable laws and regulations.</text></subparagraph><subparagraph id="HCD2F160CF29E4FBA98E761CA6B212B6B"><enum>(C)</enum><header>Patient choice</header><text display-inline="yes-display-inline">Nothing in this subsection shall be construed as affecting the ability of an individual who is a participant or beneficiary of a group health plan and who is being prescribed a schedule II, III, IV, or V controlled substance that is a prescription drug covered under the plan to designate a particular pharmacy to dispense such controlled substance to the extent consistent with the requirements under this subsection.</text></subparagraph></paragraph><paragraph id="HB38AE2DA920043819FCA26B8FFAD8713"><enum>(4)</enum><header>Prohibitions</header><text>The policies established pursuant to paragraph (1) by a group health plan may not—</text><subparagraph id="H92AE123AC85F40FC850ABFF36688BAD9"><enum>(A)</enum><text display-inline="yes-display-inline">require dispensers of a schedule II, III, IV, or V controlled substance to confirm that the prescription for the controlled substance was electronically issued by a health care practitioner in accordance with such policies, as described in paragraph (1); </text></subparagraph><subparagraph id="H97191B3C4D87457D8EF78D9BB7F422D9"><enum>(B)</enum><text>require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a practitioner’s compliance with such policies; or</text></subparagraph><subparagraph id="HC1B313ACA45049AFB827AF6B83E4045B"><enum>(C)</enum><text>reject, deny, or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued.</text></subparagraph></paragraph><paragraph id="H2BF70CA97EC4433EAAF69EBBFFD59F50"><enum>(5)</enum><header>Consultation requirement for rulemaking</header><text>In promulgating regulations to carry out this subsection, the Secretary, Secretary of the Treasury, and Secretary of Labor shall jointly consult with dispensers of controlled substances, State insurance regulators, and health care practitioners.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section></legis-body></bill> 

